The ROS1 Experts


The ROS1 researchers and clinicians listed on this page are the most familiar with ROS1+ cancers, treatments, and clinical trials. If you have questions about the next step in treating ROS1+ cancer, most of them available for second opinions or physician consults. Some offer remote second opinions (submit your medical records and have a consultation by phone), which are not covered by insurance.

D Ross Camidge, MD, PhD
University of Colorado, Denver, Colorado USA
Remote second opinion available

Jeffrey W. Clark, MD
Massachusetts General Hospital, Boston, Massachusetts, USA
Remote second opinion available
Daniel B. Costa, MD, PhD
Dana-Farber/Harvard Cancer Center, Boston, Massachusetts, USA
Remote second opinion available

Robert C. Doebele, MD, PhD
University of Colorado, Denver, Colorado USA
Remote second opinion available

Sai-Hong Ignatius Ou, MD, PhD
University of California, Irvine, California, USA

Gregory J. Riely, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, New York, USA

Ravi Salgia, MD, PhD
City of Hope, Duarte, California, USA

Geoffrey I. Shapiro, MD, PhD
Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Remote second opinion available

Alice T. Shaw, MD, PhD
Massachusetts General Hospital, Boston, Massachusetts, USA
Remote second opinion available

Ben Solomon, MBBS, PhD
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

Last updated 25-May-2017